INVO Fertility Inc. (NASDAQ:IVF) stock was trading lower Monday after nearly doubling during Friday’s session, as investors appeared to lock in gains following the sharp rally.
The pullback comes after the microcap stock surged 97.58% on Friday, making Monday’s decline consistent with profit-taking and heightened volatility often seen in low-priced stocks after outsized moves.
Acquisition And Nasdaq Update Fueled Friday’s Rally
Friday’s rally followed two key company announcements disclosed in a Form 8-K filing.
The healthcare fertility company revealed that its wholly owned subsidiary, INVO Centers LLC, has consummated the acquisition of 100% of the membership interests of HRCFG LLC. HRCFG previously managed and operated the "Innovative Fertility Specialists" joint venture clinic in Birmingham, Alabama.
Under the Membership Interest Transfer Agreement, INVO acquired the interests from sellers Karen Hammond, Lisa Ray and Nicholas Cataldo for a combined purchase price of $175,001.
This transaction includes $1.00 paid in cash at closing and $175,000 in additional consideration to be covered through pro-rata monthly installments and future free cash flow. Moving forward, INVO will incorporate the clinic’s accounts into its consolidated financial statements on a prospective basis.
Investor sentiment also improved after Nasdaq closed its non-compliance matter related to delayed financial filings. The exchange notified the company on June 23 that it had regained compliance with the Timely Filing Rule after submitting its quarterly report on June 22.
IVF Stock Price Activity: INVO Fertility shares were down 9.80% at $2.210 during premarket trading on Monday, according to Benzinga Pro data.
Photo via Shutterstock
Login to comment